| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |